An open-label phase 1 trial of the safety and efficacy of daily subcutaneous spl-108 injections in combination with paclitaxel in patients with platinum-resistant, CD44+, advanced ovarian epithelial cancer.
Saved in:
| Title: | An open-label phase 1 trial of the safety and efficacy of daily subcutaneous spl-108 injections in combination with paclitaxel in patients with platinum-resistant, CD44+, advanced ovarian epithelial cancer. |
|---|---|
| Authors: | Girda, E.1 (AUTHOR), De Meritens, A. Buckley1 (AUTHOR), Leiser, A.1 (AUTHOR), Stephenson, R.D.1 (AUTHOR), Nelson, D.1 (AUTHOR), Rodriguez-Rodriguez, L.1 (AUTHOR) |
| Source: | Gynecologic Oncology. Jul2019:Supplement 1, Vol. 154, p93-93. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
